Pages that link to "Q41704890"
Jump to navigation
Jump to search
The following pages link to Potentiation of retinoid-induced differentiation of HL-60 and U937 cell lines by cytokines (Q41704890):
Displaying 27 items.
- Cloning of a gene (RIG-G) associated with retinoic acid-induced differentiation of acute promyelocytic leukemia cells and representing a new member of a family of interferon-stimulated genes (Q24655577) (← links)
- Analysis of the molecular genetics of acute promyelocytic leukemia in mouse models (Q31922478) (← links)
- Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies (Q33358735) (← links)
- In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications (Q33739259) (← links)
- The Present Status in All-trans Retinoic Acid (ATRA) Treatment for Acute Promyelocytic Leukemia Patients: Further Understanding and Comprehensive Strategy are Required in the Future (Q35196474) (← links)
- Topical and systemic retinoid therapy for cutaneous T-cell lymphoma (Q35622824) (← links)
- Leukemia cells and the cytokine network: therapeutic prospects (Q35634259) (← links)
- Leukocyte alkaline phosphatase a specific marker for the post-mitotic neutrophilic granulocyte: regulation in acute promyelocytic leukemia (Q36846274) (← links)
- Retinoids in the management of head and neck cancer. An update (Q40698402) (← links)
- Enhanced apoptosis and radiosensitization by combined 13-cis-retinoic acid and interferon-alpha2a; role of RAR-beta gene (Q40770152) (← links)
- Effects of hyperthermia and granulocyte-macrophage colony-stimulating factor on the differentiation of human leukemic cell line U937. (Q41022011) (← links)
- Growth inhibition of DU-145 prostate cancer cells by a Bcl-2 antisense oligonucleotide is enhanced by N-(2-hydroxyphenyl)all-trans retinamide (Q41056926) (← links)
- Establishment of a GM‐CSF‐dependent megakaryoblastic cell line with the potential to differentiate into an eosinophilic lineage in response to retinoic acids (Q41062233) (← links)
- Cooperative effects of interferon-γ on the induction of NADPH oxidase by retinoic acid or 1,25(OH)2-vitamin D3 in monocytic U937 cells (Q41281912) (← links)
- Chemoprevention of respiratory tract cancer (Q41519927) (← links)
- Mechanisms of resistance to Leishmania aethiopica. I. Interferon-gamma in combination with a cytokine (not tumor necrosis factor-alpha) is required, but cannot act alone in the inhibition of intracellular forms of L. aethiopica in THP1 cells (Q41604158) (← links)
- Interleukin-4 inhibits the differentiation of mouse myeloid leukemia M1 cells induced by dexamethasone, D-factor/leukemia inhibitory factor and interleukin-6, but not by 1 alpha,25-dihydroxyvitamin D3. (Q41660478) (← links)
- Antiproliferative activity of retinoids, interferon α and their combination in five human transformed cell lines (Q45260236) (← links)
- Influence of L-glutamic acid on binding of interleukin-1beta, tumour necrosis factor-alpha and interleukin-6 to HL-60 cells (Q47809801) (← links)
- In vitro radiosensitization of human cervical carcinoma cells by combined use of 13-cis-retinoic acid and interferon-alpha2a (Q47886106) (← links)
- Retinoic acid induces apoptosis of human CD34 hematopoietic progenitor cells: involvement of retinoic acid receptors and retinoid X receptors depends on lineage commitment of the hematopoietic progenitor cells (Q51090675) (← links)
- In vitro interaction between retinoids and cytokines in human myeloid leukaemia cells (Q53796861) (← links)
- All-trans retinoic acid in acute promyelocytic leukemia: preliminary results in Cuba (Q67550274) (← links)
- Restoration of all-trans retinoic acid sensitivity by interferon in acute promyelocytic leukaemia (Q68322930) (← links)
- Combination of alpha-interferon 2a (alpha-IFN 2a) and 13-cis-retinoic acid (13cRA) in recurrent, pre-treated squamous-cell carcinoma of head and neck (SCCHN) (Q73074346) (← links)
- All-trans-retinoic acid upregulates TNF receptors and potentiates TNF-induced activation of nuclear factors-kappaB, activated protein-1 and apoptosis in human lung cancer cells (Q73803155) (← links)
- Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma (Q77214079) (← links)